Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,794 total articles
Microsoft's commercial AI stack and Azure demand are driving durable revenue leverage. Fundamentals - including $72.9B free cash flow, 30% ROE, and a $3.06T market cap - give the company scope to invest and defend share. This trade idea takes a constructive, risk-managed long on MSFT at $412 with a $490 target over the next 180 trading days and a $…
Slide Insurance combines rapid premium growth with unusually strong free cash flow and a low earnings multiple. At about $18.60 the stock trades at roughly 5x earnings and under 2x book, leaving room for upside as the company scales its specialty homeowners and landlord lines. The principal hazard is catastrophe exposure in 2026 hurricane season an…
Aris Mining (ARIS) has one of the steepest production growth profiles among mid-tier gold producers and is trading well below its 52-week high after a modest pullback. With a market cap of $3.57B, solid float and institutional interest, the setup favors a long trade that targets a re-test of the $23 area within a multi-month horizon while using a t…
Apple reported a strong earnings cadence that lifted the stock above $280. Solid free cash flow ($129.2B trailing) and a high-margin services mix underpin growth, but P/E near 33.5, a 52-week high test and potential supply or margin pressures argue for a disciplined entry with a nearby stop.
MTU Aero Engines (MTUAY) is trading near its 52-week low after a sharp pullback from February highs. The company's durable MRO franchise, exposure to next-gen propulsion programs, and a modest valuation (market cap $18.1B, PE ~15.5) make this an actionable mid-term long. Trade plan: enter at $167.50, stop $155.00, target $205.00 (mid-term, 45 tradi…
The iShares MSCI Japan ETF (EWJ) sits near its highs with constructive technicals and macro policy catalysts behind the rally. With a market cap of $20.29B, a PE of 19.6 and PB near 1.95, EWJ looks reasonably valued for continued upside tied to fiscal stimulus, corporate governance reforms and a weaker yen. This trade plan targets $95 with a $86 st…
Jet fuel is spiking and the air-transport sector is jittery, but LATAM's post-bankruptcy network rationalization, improving unit economics and a still-reasonable valuation argue for a measured long swing. This trade targets mean reversion back toward the mid-50s while protecting capital under an explicit stop.
Credo Technology is winning in high-speed electrical interconnects and just bought silicon photonics capability. Revenue and EPS growth are accelerating; market pricing already reflects a lot of optimism, but the combination of product-led market share and optical expansion makes Credo a compelling long-term trade with defined risk-management.
EverQuote (EVER) is seeing a fresh rally driven by improving marketing economics and heavy intraday volume. Strong profitability metrics (EPS $2.81), meaningful free cash flow ($90.3M), and an attractive EV/EBITDA of ~4.85 underpin an upgrade to a tactical long. Trade plan targets a mid-term upside while respecting short-term volatility and elevate…
DigitalOcean is riding outsized AI demand from developers and SMBs while aggressively expanding capacity. Recent prints show rapid AI ARR growth, institutional buying and a capital raise dedicated to infrastructure. Valuation is rich but the momentum and low days-to-cover short interest create a favorable risk/reward for a mid-term long. Entry at $…
Dycom just cleared its 52-week high and enters a new phase after closing its Power Solutions acquisition. With a record $9.5 billion backlog and fiscal 2027 revenue guide of $6.85-7.15 billion, the setup favors a mid-term buy. Trade plan, targets, and risks laid out below.
Micron surged into new territory after the 245TB Micron 6600 ION SSD and accelerating memory price inflation. Fundamentals are solid - $10.3B in free cash flow, ROE north of 33% and a sub-0.15 debt/equity - but the stock is stretched: current price $642.66, 52-week high $651.74, RSI ~82. My trade: trim size at $642.66, take profits to lock gains, r…
Lam Research reported record Q3 revenue of $5.84B and raised guidance, with memory capex and AI demand driving order flow. At a market cap near $348B and P/E ~48, the stock is richly priced but justified by roughly 30% growth expectations, exceptional returns on capital and improving margins. Trade plan: enter at $280.00, target $365.00, stop $245.…
Microsoft is transitioning from a narrative-weighted AI bet to a monetization-focused strategy. With a $3.05 trillion market cap, strong free cash flow ($72.9B), low leverage and enterprise-first distribution, MSFT looks buyable on dips. This trade expects AI revenue conversion to accelerate over the next 180 trading days as Microsoft reduces singl…
Alphabet is trading at an implied market cap of roughly $460B and sits at the center of a multiyear AI replatforming. This trade idea argues for a controlled long position that leans on Alphabet's enterprise AI lock-in, ad resilience and cloud AI momentum, while acknowledging regulatory and competitive headwinds. Exact trade plan included for a lon…
Fresenius Medical Care (FMS) is trading near its 52-week low while carrying a sub-1 P/B and single-digit P/E relative to its longer-term profile. Technicals are deeply oversold, and the stock yields roughly 2.5% with an upcoming ex-dividend date. This trade idea sets a precise entry, stop and target for a long-term rebound play over 180 trading day…
SEMHF has pulled back into the low $40s amid heavy shorting and technical weakness. The company’s razor-and-blades revenue mix (equipment sales followed by recurring consumables and service) suggests outsized recovery potential if China volumes and service contracts normalize. This trade targets a mean reversion toward the 50-day average and beyond…
Charter rates for LPG carriers have moved beyond the levels that underpinned my prior bull case. Dorian LPG's balance sheet, cash flow generation, and a healthy dividend create a favorable risk-reward for a mid-term long trade. Entry at $39.82, stop at $36.00, target $48.00 (mid-term 45 trading days).
Viking Therapeutics (VKTX) is a small-cap clinical-stage biotech with an injectable GLP-1/GIP dual agonist, VK2735, that has shown rapid weight loss and tolerability in early data. The market is pricing in big upside: the Street consensus sits near $93.59, implying roughly 170% from today's ~$30.87. This trade idea outlines a long position sized fo…
Zoom is trading near $108 after a steady recovery. The company now shows enterprise traction, high free cash flow ($1.92B trailing), strong returns on capital, and a clean balance sheet. We recommend a long trade targeting $132 over a 180-trading-day horizon with a $95 stop, balancing momentum with valuation and regulatory risks.
KKR trades at about $102 with a market cap near $90.7B but carries a private-assets engine and an expanding insurance business that together produce recurring, less-cyclical fee revenue and outsized realizations. Near-term headlines around private credit are noisy; the buy thesis: durable fee growth, attractive realizations (example: Atlantic Aviat…
Shares of AngloGold Ashanti (AU) have pulled back on headline risk tied to Ghana. The business fundamentals - $46.3B market cap, a 3.9% dividend yield, and a mid-teens P/E - argue the selloff is more sentiment than reality. This trade idea outlines a mid-term (45 trading days) swing long with a clear entry, stop, and target while flagging the gover…
Micron's share price has raced higher on AI-driven demand, but the stock sits at elevated valuation multiples, an overbought technical profile, and a memory cycle that historically reverses sharply. I outline three concrete reasons to sell, provide an actionable mid-term trade plan, and list the catalysts that could trigger a pullback as well as wh…
Estee Lauder (EL) has been swinging from 52-week extremes and is sitting in a technical pocket that favors a disciplined long swing. Valuation metrics (EV/EBITDA ~13.9, P/S ~1.93) and steady free cash flow ($1.285B) mean the risk/reward looks attractive on a measured entry after recent headline-driven selloffs. This trade idea lays out a concrete e…
Nektar (NKTR) rallied from a $7.99 low in mid-2025 to roughly $86 today, yet the market is pricing the company like a pure-play development-stage drugmaker with limited cash and negative free cash flow. I lay out a long trade with entry, stop, and target, plus the catalysts and legal risks that will determine the next leg of performance.
